Based on the findings obtained on growth inhibition following treatment with 1,600 ng/ml leptin, cell signaling and cell cycle changes were assessed to determine the underlying mechanisms responsible for growth inhibition in the two breast cancer cell lines. The gene discussed is LEP; the disease is breast cancer.